Identifying Changes of Brain Regional Homogeneity and Cingulo-Opercular Network Connectivity in First-Episode, Drug-Naïve Depressive Patients With Suicidal Ideation.
functional MRI
major depressive disorder
regional homogeneity
structure connectivity
suicidal ideation
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2022
2022
Historique:
received:
17
01
2022
accepted:
31
01
2022
entrez:
21
3
2022
pubmed:
22
3
2022
medline:
22
3
2022
Statut:
epublish
Résumé
Adult patients with major depressive disorder (MDD) may not actively reveal their suicidal ideation (SI). Therefore, this study is committed to finding the alterations in the cingulo-opercular network (CON) that are closely related to SI with multi-imaging methods, thus providing neuroimaging basis for SI. A total of 198 participants (129 MDD patients and 69 healthy controls) were recruited and evaluated with the Montgomery-Asberg Depression Rating Scale (MADRS). The healthy individuals formed the HC group, while the MDD patients were subdivided into no SI MDD (NSI, Compared to those of the HC group, MDD ReHo values and gray matter volume (GMV) were consistently found abnormal in CON. ReHo values and GMV of the right orbital inferior frontal gyrus (ORBinf.R) in the MDD group decreased with the increase of SI. Compared to the HC group, the MDD patients showed enhanced structural connectivity of three pairs of brain regions in CON [ACC.L-left superior frontal gyrus (SFG.L), SFG.L-left middle temporal gyrus (MTG.L), and the SFG.L-left post-central gyrus (PoCG.L)]. Compared with that of the NSI and MSI groups, the structural connectivity of three pairs of brain regions in CON is enhanced in the SSI groups [ORBinf.L-right ventral posterior cingulate gyrus (VPCC.R), VPCC.R-SFG.R, and SFG.R-PoCG.R]. Our findings showed the distinctive ReHo, GMV, and SCN pattern of CON in MDD patients with SI; and with the severity of suicide, abnormal brain regions increased. Our finding suggested that MDD patients with different severity of SI have different neuroimaging changes.
Identifiants
pubmed: 35310111
doi: 10.3389/fnins.2022.856366
pmc: PMC8924659
doi:
Types de publication
Journal Article
Langues
eng
Pagination
856366Informations de copyright
Copyright © 2022 He, Ping, Chu, Zeng, Shen and Xu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neuroimage. 2010 Oct 15;53(1):1-15
pubmed: 20547229
Nat Rev Neurosci. 2013 May;14(5):322-36
pubmed: 23531697
J Affect Disord. 2017 Jun;215:213-217
pubmed: 28340447
J Affect Disord. 2004 Nov 15;83(1):73-7
pubmed: 15546648
J Neurosci. 2017 Nov 1;37(44):10529-10540
pubmed: 29093055
Neuroimage. 2006 Jul 1;31(3):993-1003
pubmed: 16624590
Phys Rev Lett. 2018 Oct 12;121(15):158101
pubmed: 30362787
Neuroimage. 1998 Feb;7(2):133-49
pubmed: 9558645
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2035-40
pubmed: 19188601
Psychiatry Res Neuroimaging. 2018 Aug 30;278:77-91
pubmed: 29929763
Am J Psychiatry. 2020 Aug 1;177(8):754-763
pubmed: 32252540
Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11073-8
pubmed: 17576922
Front Psychiatry. 2021 Feb 16;12:618805
pubmed: 33679477
Trends Neurosci. 2012 Sep;35(9):527-35
pubmed: 22658924
Neuroimage. 2010 Jul 1;51(3):1275-81
pubmed: 20302946
Am J Psychiatry. 2017 Jul 1;174(7):667-675
pubmed: 28135845
Neuron. 2012 Mar 22;73(6):1204-15
pubmed: 22445347
Neuropsychopharmacology. 2015 Jun;40(7):1640-8
pubmed: 25598428
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19067-72
pubmed: 20956328
Brain Stimul. 2018 May - Jun;11(3):575-581
pubmed: 29454551
Biol Psychiatry. 2019 Mar 15;85(6):443-453
pubmed: 30470559
Br J Psychiatry. 1979 Apr;134:382-9
pubmed: 444788
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
BMC Psychiatry. 2022 Jan 4;22(1):3
pubmed: 34983460
Eur Neuropsychopharmacol. 2012 Jan;22(1):1-16
pubmed: 21723712
J Neurosurg. 2018 Jun;128(6):1865-1872
pubmed: 28862541
Mol Psychiatry. 2017 Aug;22(8):1149-1154
pubmed: 27956745
JAMA Psychiatry. 2015 Jun;72(6):603-11
pubmed: 25785575
Neuroimage. 2012 Jan 16;59(2):1239-48
pubmed: 21884805
Int J Psychophysiol. 2020 Sep;155:99-104
pubmed: 32522512
Transl Psychiatry. 2020 May 29;10(1):172
pubmed: 32472038
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
JAMA. 1994 Dec 14;272(22):1757-62
pubmed: 7966924
Biol Psychiatry. 2018 Feb 1;83(3):263-272
pubmed: 28886760
Neuroimage. 2011 Jan 15;54(2):1607-14
pubmed: 20832482
J Affect Disord. 2017 Apr 01;212:78-85
pubmed: 28157550
Cereb Cortex. 2004 Jan;14(1):11-22
pubmed: 14654453
Brain Imaging Behav. 2020 Dec;14(6):2542-2552
pubmed: 32157476
Front Hum Neurosci. 2014 Oct 22;8:824
pubmed: 25374525
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:287-302
pubmed: 30118825
Psychol Med. 2015 Dec;45(16):3571-80
pubmed: 26266877
Mol Psychiatry. 2020 Jul;25(7):1550-1558
pubmed: 31758093
Front Hum Neurosci. 2018 Nov 01;12:437
pubmed: 30443211
BMC Med. 2015 Apr 06;13:72
pubmed: 25879936
Transl Psychiatry. 2016 Jun 07;6(6):e835
pubmed: 27271861
Am J Psychiatry. 2019 Nov 1;176(11):949-956
pubmed: 31581800
Biol Psychiatry. 2009 May 1;65(9):808-11
pubmed: 19103442
Am J Psychiatry. 2019 Jul 1;176(7):552-563
pubmed: 31164006
Am J Psychiatry. 2020 Aug 1;177(8):716-726
pubmed: 32252538
Psychol Med. 2020 Feb;50(3):384-395
pubmed: 30722798
Schizophr Bull. 2021 Oct 21;47(6):1740-1750
pubmed: 33860786
Brain. 2014 Aug;137(Pt 8):2382-95
pubmed: 25057133
JAMA Psychiatry. 2021 Feb 1;78(2):161-170
pubmed: 33079133
World J Biol Psychiatry. 2011 Aug;12(5):319-39
pubmed: 21385016
J Nerv Ment Dis. 1990 Mar;178(3):147-9
pubmed: 2307967